We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
-17.41%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$221M
AUM Growth
-$69.8M
Cap. Flow
-$14.1M
Cap. Flow %
-6.38%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$13.2M

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$13.2M
2
INDA icon
iShares MSCI India ETF
INDA
+$7.19M
3
EPI icon
WisdomTree India Earnings Fund ETF
EPI
+$6.96M

Sector Composition

Rank Sector Weight
1 Healthcare 92.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$183M 82.84%
10,030,700
-688,700
-6% -$13.2M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$22.3M 10.09%
4,468,835
+1,650,000
+59% +$13.2M
INDA icon
3
iShares MSCI India ETF
INDA
$6.71B
$7.85M 3.55%
171,200
-148,800
-47% -$7.19M
EPI icon
4
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$7.8M 3.52%
213,800
-186,200
-47% -$6.96M

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q4 2021 Portfolio in Review

As of Q4 2021, Meditor Group held 4 positions worth $221M, down 24% from $291M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meditor Group withdrew a net $14.1M in Q4 2021, reducing 3 holdings. Its largest reduction was Exelixis, cutting an estimated $13.2M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 90% a quarter earlier.

Against the trend, Meditor Group added an estimated $13.2M to Esperion Therapeutics.

  • Meditor Group added most to Esperion Therapeutics in Q4 2021, an estimated $13.2M increase.
  • Meditor Group's biggest Q4 2021 reduction was Exelixis, cutting an estimated $13.2M.
  • Meditor Group's ten largest holdings make up 100% of its $221M portfolio in Q4 2021.
  • Meditor Group opened 0 new positions and closed 0 in Q4 2021.
  • Meditor Group's portfolio value fell 24% quarter-over-quarter to $221M.

Based on Meditor Group's 13F filing for Q4 2021, filed 5 Jan 2022.